Document is current
Any future updates will be listed below
-
Authors
Reinecke, Maria
Brear, Paul http://orcid.org/0000-0002-4045-0474
Vornholz, Larsen http://orcid.org/0000-0002-8054-5603
Berger, Benedict-Tilmann http://orcid.org/0000-0002-3314-2617
Seefried, Florian
Wilhelm, Stephanie http://orcid.org/0000-0002-1066-6565
Samaras, Patroklos http://orcid.org/0000-0001-6042-1585
Gyenis, Laszlo
Litchfield, David William http://orcid.org/0000-0002-2425-6620
Médard, Guillaume http://orcid.org/0000-0002-4782-4029
Müller, Susanne http://orcid.org/0000-0003-2402-4157
Ruland, Jürgen
Hyvönen, Marko http://orcid.org/0000-0001-8683-4070
Wilhelm, Mathias http://orcid.org/0000-0002-9224-3258
Kuster, Bernhard http://orcid.org/0000-0002-9094-1677
- License Information
-
More Information
Article History
Received: 16 June 2022
Accepted: 22 September 2023
First Online: 30 October 2023
Competing interests
: M.W. and B.K. are founders and shareholders of OmicScouts GmbH and MSAID GmbH. They have no operational role in either company. B.-T.B. is a cofounder and the CEO of CELLinib GmbH (Frankfurt am Main, Germany). The remaining authors declare no competing interests.
